Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Mind Cure Health Inc
(OP:
MCURF
)
N/A
UNCHANGED
Last Price
Updated: 2:36 PM EDT, Sep 11, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Mind Cure Health Inc
Cannabis Movers & Shakers: TrueGreen, PSYC, BioSteel Sports Nutrition, Perfect Union, YourWay Cannabis Brands
April 12, 2022
Via
Benzinga
Are Psychedelics Stocks In Trouble Or Is The Market Reaching Maturity?
April 04, 2022
Long gone is the heyday of investor enthusiasm and easy access to capital that marked the launch of the psychedelics industry into the public markets. In recent months, psychedelics stocks entered into...
Via
Benzinga
Psyched: MindCure Shuts Down Operations, Novamind And MindMed Partner For Study
March 22, 2022
The psychedelics space was shaken up on the news thatMindCure Health (OTC: MCURF) was shutting down operations.
Via
Benzinga
Mind Cure Health Is Shutting Down All Operations, Citing Lack Of Funds To Move Forward
March 16, 2022
Mind Cure Health Inc. (CSE:MCUR) (OTCQX:
Via
Benzinga
Benzinga Expands Footprint into the Psychedelic Industry with the Launch of the Benzinga Psychedelic Advisory Council
March 09, 2022
DETROIT, March 4, 2022 /PRNewswire/ -- The Benzinga Psychedelics Advisory Council is a collective of the leading minds and voices in the ...
Via
Benzinga
Psychedelics As A Potential Form Of Treatment For Traumatic Brain Injuries
April 20, 2021
In recent years, there has been a re-emergence in the study of psychedelic drug...
Via
Benzinga
Epigenetics, Psychedelics and Stem Cell Therapy are Topics of the Life Sciences Virtual Investor Conference Launching This Thursday
December 14, 2021
Photo by Chris Montgomery on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
This Company Is Making Synthetic Psychedelics With a Goal To Combat Mental Illness
December 08, 2021
Photo by Michael Longmire on...
Via
Benzinga
EXCLUSIVE: Benzinga Interviews Mind Cure CEO Kelsey Ramsden with Updates on Latest Press Release
November 09, 2021
Image by: iStock The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored conte...
Via
Benzinga
Compass Pathways 2.0: A New Rally In Psychedelic Stocks?
November 04, 2021
Compass Pathways' IPO sparked a sector-wide rally in 2020. Now CMPS is on the move again. Is history about to repeat?
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Psyched: MindMed's MDMA Program For Autism, Small Pharma's New Patent, NovaMentis' Orphan Drug Designation
November 01, 2021
The Week In Psychedelics:
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
The Week In Psychedelics
Via
Benzinga
Psychedelic Stocks: Financial Strength, Growth Potential, Compelling Valuations
October 12, 2021
Blue-chip stocks: grossly inflated valuations and loaded with debt. Psychedelic stocks: lean valuations and loaded with cash. A very attractive option in uncertain markets.
Via
Talk Markets
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
October 13, 2021
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...
Via
Benzinga
Psyched: Elon Musk Discusses Psychedelics, Delix Raises $70M, MindCure To Study MDMA In Female Sexual Dysfunction
October 04, 2021
The Week In Psychedelics:
Via
Benzinga
Can MDMA (Or Ecstasy) Improve Sexual Desire in Women? MindCure Launches Research Program To Find Out
September 27, 2021
Mind Cure Health Inc. (CSE:MCUR) (OTCQB:
Via
Benzinga
Is Ketamine A Psychedelic? Depends On Who You Ask
September 22, 2021
Ketamine, an FDA-approved anesthetic drug, has recently become the star of the psychedelic medicine movement. As p...
Via
Benzinga
Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry?
September 09, 2021
By Natan Ponieman and Javier Hasse The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate...
Via
Benzinga
Psychedelic Drug Industry Report Card For 2021
September 01, 2021
In assessing the psychedelic drug industry, a primary focus for investors is drug development.
Via
Talk Markets
Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold
August 30, 2021
Contents
Via
Benzinga
Which Psychedelic Drug Has The Most Commercial Potential?
August 10, 2021
As the Mental Health Crisis has become a mental health pandemic, clinical research on psychedelic drugs is showing that these substances are the best – and only – option to address this crisis.
Via
Talk Markets
How To Invest In "Magic Mushrooms" (Psychedelics)
July 09, 2021
A look at psychedelics as stock market investment opportunities and identifying alternative strategies on how to invest.
Via
Talk Markets
Psyched: GH Research Debuts on Nasdaq, Compass Reaches Psilocybin Research Milestone, Maxim Gives BUY Rating to 10 Psychedelics Companies
July 02, 2021
Irish 5-MeO-DMT Company GH Research Debuts On Nasdaq GH Research, a Dublin-based company studying the potential o...
Via
Benzinga
Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And More
June 30, 2021
Institutional analysts are taking a liking to the industry ...
Via
Benzinga
Professional Sports Turn To Psychedelics
May 15, 2021
Psychedelic drug R&D is rapidly expanding into many of the largest medical treatment markets.
Via
Talk Markets
Why Smaller Psychedelics Companies Should Start Catching Up To The Sector Leaders
May 05, 2021
Concentration of ownership in psychedelic drug stocks has reached a new extreme. We explain how and why we don't see this trend as being sustainable.
Via
Talk Markets
The Next Psychedelic Stock To Uplist On The Nasdaq?
May 04, 2021
As MindMed Inc makes its long-awaited move to the Nasdaq, the obvious question is: who's next?
Via
Talk Markets
Second-Chance Buying Opportunity With Psychedelic Stock Warrants
April 27, 2021
Psychedelic stock warrants delivered epic returns for investors in the big rally in these stocks in 2020. After the pullback in 2021, some of these warrants are again looking attractive.
Via
Talk Markets
Déjà Vu: 2021 Slump In Psychedelic Stocks Mirrors 2020
April 21, 2021
Charts for most psychedelic drug stocks look terrible in recent weeks. The same was true in the summer of 2020 -- immediately before these stocks exploded higher. Deja vu?
Via
Talk Markets
Cannabis Movers & Shakers: TILT, BRNT, ECGI, Alcanna, WeedMD, Mind Cure, Flowr Corporation, VIVO, Cannabiz, Team Hytiva
April 16, 2021
TILT Holdings Announces Two New Additions To Its Leadership Team TILT Holdings Inc. (CSE:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.